Mcgowan JV, Chung R, Maulik A et al (2017) Anthracycline Chemotherapy and Cardiotoxicity[J]. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-016-6711-0

Article  PubMed  PubMed Central  Google Scholar 

Sun Y, Liu Y, Ma X et al (2021) The Influence of Cell Cycle Regulation on Chemotherapy[J]. Int J Mol Sci. https://doi.org/10.3390/ijms22136923

Article  PubMed  PubMed Central  Google Scholar 

Xing W, Wen C, Wang D et al (2022) Cardiorenal protective effect of Costunolide against Doxorubicin-Induced toxicity in rats by modulating oxidative stress, inflammation and Apoptosis[J]. Molecules 27(2024–12–22):2122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakamura F, Arai H, Tokita K et al (2020) PECAM is an effective and safe Anthracycline-Containing Third-Line regimen for patients with relapsed or refractory Non-Hodgkin Lymphoma[J]. Leuk Lymphoma/Leukemia Lymphoma 62(1):239–242

Article  PubMed  Google Scholar 

Jin H, Xu J, Sui Z et al (2023) Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and Meta-Analysis.[J]. Front Cardiovasc Med 10(2024–12–22):10

Google Scholar 

Timoshnikov VA, Selyutina OY, Polyakov NE et al (2022) Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine[J]. Int J Mol Sci. https://doi.org/10.3390/ijms23031247

Article  PubMed  PubMed Central  Google Scholar 

Turilli-Ghisolfi ES, Lualdi M, Fasano M (2023) Ligand-Based Regulation of Dynamics and Reactivity of Hemoproteins[J]. Biomolecules. https://doi.org/10.3390/biom13040683

Article  PubMed  PubMed Central  Google Scholar 

Huang W, Xu R, Zhou B et al (2022) Clinical manifestations, monitoring, and prognosis: A review of cardiotoxicity after antitumor Strategy[J]. Front Cardiovasc Med 9(2024–12–22):912329

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Boogaard WMC, Komninos DSJ, Vermeij WP (2022) Chemotherapy Side-Effects: Not All DNA Damage is Equal [J]. Cancers. https://doi.org/10.3390/cancers14030627

Article  PubMed  PubMed Central  Google Scholar 

Vitale R, Marzocco S, Popolo A (2024) Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account[J]. Int J Mol Sci 25(13):7477

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang J, Wu R, Chen L et al (2022) Understanding anthracycline cardiotoxicity from mitochondrial Aspect[J]. Front Pharmacol 13(2025–1–19):811406

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie S, Sun Y, Zhao X et al (2024) An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity[J]. Front Pharmacol 15(2025–1–19):1406247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q, Yang J, Zhang H (2019) Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy[J]. Biomed Pharmacother 109:71–83

Article  CAS  PubMed  Google Scholar 

Tang WW, Biomedical Literature (2018) Faculty Opinions Recommendation of 2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed under the Auspices of the ESC Committee for Practice Guidelines: the Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC).[J]. Faculty Opinions– Post-Publication Peer Review of the. 2025(2025-1-19): Abbreviations and acronyms2770P-Abbreviations and acronyms27701P

Kim Y, Seidman JG, Seidman CE (2022) Genetics of Cancer Therapy-Associated Cardiotoxicity[J]. J Mol Cell Cardiol. https://doi.org/10.1016/j.yjmcc.2022.03.010

Article  PubMed  PubMed Central  Google Scholar 

Balaji S, Antony AK, Tonchev H et al (2023) Racial disparity in Anthracycline-induced cardiotoxicity in breast Cancer Patients[J]. BIOMEDICINES 11(2025–1–19):40

Google Scholar 

Belger C, Abrahams C, Imamdin A et al (2024) Doxorubicin-induced Cardiotoxicity and Risk Factors[J]. Int J Cardiol Heart Vasc. https://doi.org/10.1016/j.ijcha.2023.101332

Article  PubMed  Google Scholar 

Xiao H, Wang X, Li S et al (2021) Advances in biomarkers for detecting early Cancer Treatment-Related cardiac Dysfunction[J]. Front Cardiovasc Med 8(2025–1–19):753313

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murtagh G, Januzzi JL, Scherrer-Crosbie M et al (2023) Circulating Cardiovascular Biomarkers in Cancer Therapeutics-Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions[J]. J Am Heart Assoc. https://doi.org/10.1161/JAHA.123.029574

Article  PubMed  PubMed Central  Google Scholar 

Attanasio U, Di Sarro E, Tricarico L et al (2024) Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond[J]. Biomolecules. https://doi.org/10.3390/biom14020199

Article  PubMed  PubMed Central  Google Scholar 

Manrique CR, Park M, Tiwari N et al (2017) Diagnostic strategies for early recognition of Cancer Therapeutics–Related cardiac Dysfunction[J]. Clin Med Insights: Cardiol 11:1525638977

Google Scholar 

Nakata K, Kucukseymen S, Cai X et al (2024) Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity[J]. J Cardiovasc Magn Reson 26(1):101033

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Hou Y, Hussain M et al (2020) Machine Learning-Based risk assessment for Cancer Therapy-Related cardiac dysfunction in 4300 longitudinal oncology Patients[J]. J Am Heart Assoc 9(23):e19628

Article  Google Scholar 

Cheng C, Lee B, Nfor ON et al (2024) Using machine learning-based algorithms to construct cardiovascular risk prediction models for Taiwanese adults based on traditional and novel risk factors[J]. BMC Med Inf Decis Mak 24:199

Article  Google Scholar 

Koh J, Kim MJ (2019) Introduction of a new staging system of breast Cancer for radiologists: an emphasis on the prognostic Stage[J]. Korean J Radiol 20(1):69

Article  PubMed  Google Scholar 

Kabore EG, Guenancia C, Vaz-Luis I et al (2019) Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort Study[J]. PLoS Med 16:e1002989

Article  PubMed  PubMed Central  Google Scholar 

Gupta A, Guyomard V, Zaman MJS et al (2010) Systematic review on evidence of the effectiveness of cholesterol-lowering drugs[J]. Adv Therapy 27(6):348-364 https://doi.org/10.1007/s12325-010-0033-6

Aronow WS (2006) Management of hyperlipidemia with Statins in the older patient[J]. Clin Interv Aging 1(4):433–438

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veronese P, Hachul DT, Scanavacca MI et al (2018) Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast Cancer.[J]. PLoS ONE 13:e196763

Article  Google Scholar 

Waheed S, Dawn B, Gupta K (2016) Association of corrected QT interval with body mass index, and the impact of this association on mortality: results from the third National health and nutrition examination Survey.[J]. Obes Res Clin Pract 11:426–434

Article  PubMed  Google Scholar 

Nousiainen T, Jantunen E, Vanninen E et al (1999) Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin’s lymphoma[J]. Eur J Haematol 62(2):135–141

Article  CAS  PubMed  Google Scholar 

Nousiainen T, Vanninen E, Jantunen E et al (2002) Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction[J]. J Intern Med 251(3):228–234

Article  CAS  PubMed  Google Scholar 

Doust JA, Glasziou PP, Pietrzak E et al (2004) A systematic review of the diagnostic accuracy of natriuretic peptides for heart Failure[J]. Arch Intern Med 164:1978–1984

Article  CAS  PubMed  Google Scholar 

Skovgaard D, Hasbak P, Kjaer A (2014) BNP predicts Chemotherapy-Related cardiotoxicity and death: comparison with gated equilibrium radionuclide Ventriculography[J]. PLoS ONE 9(5):e96736